Skin Cancer News
A phase 2 trial demonstrated tumor shrinkage and improvement in reported outcomes in children with inoperable plexiform neurofibromas associated with neurofibromatosis type 1.
More research is needed to define criteria for stopping therapy.
In this study, oral cancer risk was used as a negative control since it is not associated with increased exposure to UV radiation.
A recent study documents a downward trend in melanoma incidence in adolescents and young adults, but experts disagree about the causes.
Drug companies are gathering and including expanded access data in drug submissions as real-world data, but the purpose of expanded access was never for the purpose of research.
New research shows that B cells — and not just T cells — influence whether patients respond to immunotherapy in melanoma, sarcoma, and kidney cancers.
Burden varies across states, with highest burden seen in Hawaii.
Gay, bisexual men have increased odds of skin cancer; OR significantly higher for gender-nonconforming adults.
A new study describes how the flu vaccine creates an antitumoral response in mouse models of metastatic melanoma that has spread to the lungs.
SkinVision had sensitivity of 80 percent, but accuracy poor versus expert recommendation.
One or more CTCs independently linked to melanoma relapse at six and 54 months.
Researchers aimed to identify clinicopathologic characteristics of patients with stage III melanoma who would benefit from regular CNS imaging.
Increased blood total mercury levels, methylmercury levels linked to increased odds of NMSC.
ASCO outlined advances in oncology that were the most clinically meaningful or had the biggest scientific impact from October 2018 through September 2019.
Combining PD-1 blockade with PAK4 inhibitors could boost the number of patients helped by the therapy.
Of those surveyed in rural communities, 43 percent intended to perform self-exam but did not follow through.
Short-term, long-term patient satisfaction high with Mohs micrographic surgery for melanoma in situ.
A survey found that dermatologists have more confidence in diagnosing, managing, and their personal knowledge of permanent chemotherapy-induced alopecia compared with clinicians who practice in oncology or primary care/internal medicine.
ASCO officials examined the discrepancies in financial disclosures across platforms and call for a simplified system.
Risk of death inversely proportionate to volume of patients with advanced-stage malignant melanoma treated at a facility.